Skip to main content

UPDATE 2-Roche: Tecentriq cocktail slows kidney cancer progression

* Swiss drugmaker aims to expand drug's indications (Adds analyst comment, shares)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.